Log on/register
BioMed Central home | Journals A-Z | Feedback | Support | My details
 
Open AccessResearch article

The neurotransmitter dopamine modulates vascular permeability in the endothelium

Resham Bhattacharya1* email, Sutapa Sinha1* email, Su-Ping Yang2 email, Chittaranjan Patra1 email, Shamit Dutta1 email, Enfeng Wang1 email and Debabrata Mukhopadhyay1 email

Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN, USA

Department of Pathology, Massachusetts General Hospital, Boston, MA, USA

author email corresponding author email* Contributed equally

Journal of Molecular Signaling 2008, 3:14doi:10.1186/1750-2187-3-14

Published: 28 July 2008

Abstract

Background

Vascular permeability factor/Vascular endothelial growth factor (VPF/VEGF), a multifunctional cytokine, is a potent inducer of vascular permeability, an important early step in angiogenesis. It is known that the neurotransmitter dopamine can inhibit VPF/VEGF mediated angiogenesis, in particular microvascular permeability, but the effectors of this action remain unclear.

Results

Here, we define the signaling pathway modulated by dopamine that inhibits VPF/VEGF induced vascular permeability in endothelial cells. Signals from VPF/VEGF lead to changes in the phosphorylation of tight junction protein zonula occludens (ZO-1) and adherens junction proteins like VE-cadherin and associated catenins, thus weakening endothelial cell-cell adhesion and increasing vascular permeability. We found VEGF receptor-2 (VEGFR-2) to be part of a multi-protein complex involving ZO-1, VE-cadherin and β-catenin. VPF/VEGF induced phosphorylations of VE-cadherin, β-catenin and ZO-1 were inhibited by dopamine treatment. Association of occludin with ZO-1 and ZO-1 with VE-cadherin were significantly inhibited by dopamine in VEGF treated cells. Furthermore, we identified Src as an important target for dopamine-mediated inhibition of VPF/VEGF induced permeability.

Conclusion

Taken together, our results provide molecular insights of dopamine function in the vascular endothelium and suggest a central role of Src in regulating key molecules that control vascular permeability.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.